Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
368.50Prev. Close
367.55Volume
42,637Total traded value
1.58 CrUpper Circuit
441.05Lower Circuit
294.05Fundamentals
| Market Cap | ₹3,686Cr |
| ROE | 11.59% |
| P/E Ratio(TTM) | 59.58 |
| EPS(TTM) | 6.17 |
| P/B Ratio | 6.13 |
| Dividend Yield | 0.03% |
| Industry P/E | 35.77 |
| Book Value | 59.94 |
| Debt to Equity | 0.56 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Gufic Biosciences
Gufic Biosciences is a leading pharmaceutical company in India, specializing in manufacturing a wide range of products, particularly life-saving lyophilized (freeze-dried) injections. The company's core principles are incubating, uplifting, and protecting life, which guide every decision and innovation it undertakes in the evolving healthcare landscape. In November 2023, Gufic was recognized by Forbes Asia as one of 'The Region's Top 200 Small and Midsize Companies'.;
| Parent Organisation | Gufic Biosciences Limited |
| Managing Director | Mr. Jayesh Choksi |
| NSE Symbol | GUFICBIO |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 103.18 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.33 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.60 | ||
| Wockhardt | NA (0.00%) | -195.86 |